Fabian Nietlispach
Overview
Explore the profile of Fabian Nietlispach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
3439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gilhofer T, Bokemeyer V, Schweiger V, Gehler M, Michel J, Chen M, et al.
Cardiology
. 2024 Oct;
:1-15.
PMID: 39413742
Introduction: Atrial fibrillation (AF) poses a significant risk of stroke. Left atrial appendage occlusion (LAAO) is an alternative for patients with contraindications to oral anticoagulation (OAC) or with high risk...
2.
Nietlispach F, Webb J, De Backer O
EuroIntervention
. 2024 Aug;
20(16):970-971.
PMID: 39155751
No abstract available.
3.
Gilhofer T, Schweiger V, Gehler M, Bokemeyer V, Chen M, Candreva A, et al.
Catheter Cardiovasc Interv
. 2024 Jul;
104(2):343-355.
PMID: 39031623
Background: Left atrial appendage closure (LAAC) represents an alternative to oral anticoagulation for stroke prevention in patients with non-valvular atrial fibrillation (AF). While transoesophageal echocardiography is the current standard for...
4.
Alaour B, Ferrari E, Heg D, Tueller D, Pilgrim T, Muller O, et al.
JACC Cardiovasc Interv
. 2024 Feb;
17(3):405-418.
PMID: 38355269
Background: Studies comparing long-term outcomes between non-vitamin K antagonist (VKA) oral anticoagulant agents (direct oral anticoagulant agents [DOACs]) and VKA anticoagulant agents after transcatheter aortic valve replacement (TAVR) are scarce,...
5.
Okuno T, Alaour B, Heg D, Tueller D, Pilgrim T, Muller O, et al.
JACC Cardiovasc Interv
. 2023 Dec;
16(24):2986-2996.
PMID: 38151313
Background: Stroke after transcatheter aortic valve replacement (TAVR) is associated with considerable morbidity and mortality. Predictors of stroke and the long-term risk after TAVR remain incompletely understood. Objectives: The authors...
6.
Wagener M, Reuthebuch O, Heg D, Tuller D, Ferrari E, Grunenfelder J, et al.
J Am Heart Assoc
. 2023 Jun;
12(12):e029489.
PMID: 37301760
Background In view of the rising global burden of severe symptomatic aortic stenosis, its early recognition and treatment is key. Although patients with classical low-flow, low-gradient (C-LFLG) aortic stenosis have...
7.
Wagener M, Boeddinghaus J, Gaemperli O, Raber L, Nietlispach F, Meier P, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556075
Background: Considering the global burden of cardiovascular disease, we analysed trends in interventional coronary and structural procedures over the past 16 years (2005-2021), using continuous data from the Swiss national...
8.
Mangner N, Brinkert M, Keller L, Moriyama N, Hagemeyer D, Haussig S, et al.
EuroIntervention
. 2022 Nov;
18(13):e1066-e1076.
PMID: 36440479
Background: One-third of patients undergoing transcatheter aortic valve implantation (TAVI) have an indication for long-term oral anticoagulation (OAC). Aims: We aimed to investigate whether continued non-vitamin K antagonist oral anticoagulant...
9.
Gunzinger J, Ibrahimi B, Baur J, Wiest M, Piccirelli M, Pangalu A, et al.
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943635
Transcatheter aortic valve implantation (TAVI) is an alternative to open heart surgery in the treatment of symptomatic aortic valve stenosis, which is often the treatment of choice in elderly and...
10.
Wagener M, Twerenbold R, Cook S, Gamperli O, Meier P, Muller O, et al.
Swiss Med Wkly
. 2021 May;
151:w20495.
PMID: 34000055
Since 1987 the Swiss Working Group Interventional Cardiology of the Swiss Society of Cardiology coordinates the assessment of invasive diagnostic and therapeutic heart interventions across Switzerland. The aim of this...